{"id":"https://openalex.org/W2467317325","doi":null,"title":"Prolonged Effects of an Anti-Alzheimers Drug, Galantamine Hydrobromide on Morphometric and Behavioural Aspects of Albino Mice","display_name":"Prolonged Effects of an Anti-Alzheimers Drug, Galantamine Hydrobromide on Morphometric and Behavioural Aspects of Albino Mice","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2467317325","mag":"2467317325"},"language":"en","primary_location":{"id":"mag:2467317325","doi":null,"is_oa":false,"landing_page_url":"https://www.rroij.com/open-access/prolonged-effects-of-an-antialzheimers-drug-galantamine-hydrobromide-on-morphometric-and-behavioural-aspects-of-albino-mice-1-6.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026114708","display_name":"Nirmala Kumari Borra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Borra Nirmala Kumari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111951973","display_name":"Kuna Yellamma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Yellamma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"2","first_page":"1","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.3747999966144562,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.3747999966144562,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.21860000491142273,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12891","display_name":"Medicinal Plants and Neuroprotection","score":0.16110000014305115,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/galantamine-hydrobromide","display_name":"galantamine hydrobromide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8999999761581421},{"id":"https://openalex.org/keywords/memory-enhancing-drugs","display_name":"memory-enhancing drugs","score":0.7260000109672546},{"id":"https://openalex.org/keywords/long-term-drug-effects","display_name":"long-term drug effects","score":0.7549999952316284},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7300000190734863},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8100000023841858},{"id":"https://openalex.org/keywords/morris-water-maze","display_name":"Morris water maze","score":0.7620000243186951},{"id":"https://openalex.org/keywords/spatial-learning-and-memory","display_name":"spatial learning and memory","score":0.8870000243186951},{"id":"https://openalex.org/keywords/cognitive-enhancement","display_name":"cognitive enhancement","score":0.38499999046325684},{"id":"https://openalex.org/keywords/health-drinks","display_name":"health drinks","score":0.6679999828338623},{"id":"https://openalex.org/keywords/albino-mice","display_name":"albino mice","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.7699663639068604},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.5908591747283936},{"id":"https://openalex.org/C44752575","wikidata":"https://www.wikidata.org/wiki/Q1417562","display_name":"Morris water navigation task","level":3,"score":0.5160343647003174},{"id":"https://openalex.org/C2779176119","wikidata":"https://www.wikidata.org/wiki/Q20974920","display_name":"Hydrobromide","level":2,"score":0.43961507081985474},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.43089836835861206},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4156739413738251},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.4132331907749176},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40117979049682617},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3220469057559967},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.297413170337677},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.20735260844230652},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16124099493026733},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.1586451530456543},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.10554841160774231},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2467317325","doi":null,"is_oa":false,"landing_page_url":"https://www.rroij.com/open-access/prolonged-effects-of-an-antialzheimers-drug-galantamine-hydrobromide-on-morphometric-and-behavioural-aspects-of-albino-mice-1-6.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W84943662","https://openalex.org/W659503313","https://openalex.org/W1805975457","https://openalex.org/W1968551454","https://openalex.org/W1976619844","https://openalex.org/W2018402596","https://openalex.org/W2040903782","https://openalex.org/W2050562362","https://openalex.org/W2051503211","https://openalex.org/W2072214759","https://openalex.org/W2073171609","https://openalex.org/W2093561365","https://openalex.org/W2097802864","https://openalex.org/W2116497718","https://openalex.org/W2117105394","https://openalex.org/W2124264649","https://openalex.org/W2143120360","https://openalex.org/W2145107163","https://openalex.org/W2169473035","https://openalex.org/W2169944173","https://openalex.org/W2256756668"],"related_works":["https://openalex.org/W2030185836","https://openalex.org/W2037958764","https://openalex.org/W2054770298","https://openalex.org/W2080207718","https://openalex.org/W2750165664","https://openalex.org/W2378753590","https://openalex.org/W2034963833","https://openalex.org/W2412493382","https://openalex.org/W7095194969","https://openalex.org/W2055949908"],"abstract_inverted_index":{"The":[0,49,115],"present":[1],"study,":[2],"emphasises":[3],"the":[4,22,25,46,84,97,122,132,147,186,189,200,218],"prolonged":[5],"effects":[6],"of":[7,18,24,71,100,110,188,193,207,246],"an":[8],"anti-Alzheimer\u2019s":[9],"drug,":[10],"Galantamine":[11,43],"Hydrobromide,":[12],"on":[13,83,117,140,173],"Morphometric":[14,118],"and":[15,42,55,91,93,103,128,234],"Behavioural":[16],"aspects":[17,87,119],"albino":[19,32],"mice":[20,72,105,124,149],"in":[21,74,96,131,169,185,226,232,238],"absence":[23],"disease,":[26],"AD.":[27],"One":[28],"month":[29],"old":[30],"male":[31],"mice,":[33],"Mus":[34],"musculus":[35],"(20\u00b12g)":[36],"were":[37,106],"selected":[38],"as":[39,45,89],"experimental":[40,104,123,148],"model":[41],"Hydrobromide":[44],"test":[47],"drug.":[48],"ED50":[50],"for":[51,205,240,244],"GHB":[52],"was":[53,56,66,171,181,197],"evaluated":[54],"found":[57],"to":[58,68,78,157,163],"be":[59,224],"5mg/kg":[60],"body":[61,133,153],"weight.":[62],"This":[63],"effective":[64],"dose":[65],"given":[67],"Experimental":[69],"groups":[70],"once":[73],"a":[75,126,161,182,241],"day":[76,175],"up":[77,156],"180":[79],"days":[80],"continuously.":[81],"Observations":[82],"general":[85,233],"growth":[86],"such":[88],"weight":[90,134,137],"size":[92],"also":[94],"changes":[95],"behavior":[98],"pattern":[99],"both":[101],"control":[102],"recorded":[107,125],"with":[108,135],"help":[109],"Morris":[111],"water":[112],"maze":[113],"technique.":[114],"results":[116],"revealed":[120],"that":[121,199],"steady":[127],"continuous":[129],"gain":[130],"maximum":[136,167],"(22.15%)":[138],"gained":[139],"150th":[141,145,174],"day.":[142,159],"However,":[143],"after":[144],"day,":[146],"started":[150],"losing":[151],"their":[152,247],"weights":[154],"gradually":[155],"180th":[158],"As":[160],"corollary":[162],"these":[164,194],"morphometric":[165],"changes,":[166],"elevation":[168],"performance":[170,187],"noticed":[172],"(56.69%).":[176],"From":[177],"then":[178],"onwards,":[179],"there":[180],"gradual":[183],"decline":[184],"mice.":[190],"In":[191],"view":[192],"observations,":[195],"it":[196],"concluded":[198],"memory":[201,219],"enhancing":[202,220],"drugs":[203,221],"meant":[204],"treatment":[206],"Alzheimer\u2019s":[208],"disease":[209],"or":[210],"any":[211,227],"formulated":[212],"health":[213],"drinks":[214],"containing":[215],"chemicals":[216],"mimicking":[217],"should":[222],"not":[223],"consumed":[225],"form":[228],"by":[229,235],"normal":[230],"people":[231],"young":[236],"children":[237],"particular":[239],"long":[242],"time":[243],"improvement":[245],"cognitive":[248],"skills.":[249]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}